ID   MR-5
AC   CVCL_JZ21
SY   MR 5
DR   Wikidata; Q54906552
RX   PubMed=2986245;
RX   PubMed=2988594;
CC   Doubling time: 1-3 days (PubMed=2986245; PubMed=2988594).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 6
//
RX   PubMed=2986245; DOI=10.1007/978-3-642-82372-5_6;
RA   Gropp C., Luster W., Havemann K.;
RT   "In vitro studies in small cell lung cancer cell lines.";
RL   Recent Results Cancer Res. 97:55-64(1985).
//
RX   PubMed=2988594; DOI=10.1038/bjc.1985.132;
RA   Luster W., Gropp C., Kern H.F., Havemann K.;
RT   "Lung tumour cell lines synthesizing peptide hormones established from
RT   tumours of four histological types: characterization of the cell
RT   lines and analysis of their peptide hormone production.";
RL   Br. J. Cancer 51:865-875(1985).
//